BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22710906)

  • 1. Neurologic complications of HIV infection.
    Spudich SS; Ances BM
    Top Antivir Med; 2012; 20(2):41-7. PubMed ID: 22710906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CROI 2019: neurologic complications of HIV disease.
    Ances BM; Letendre SL
    Top Antivir Med; 2019 Apr; 27(1):26-33. PubMed ID: 31137000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dementia and neurocognitive disorders due to HIV-1 infection.
    Ances BM; Ellis RJ
    Semin Neurol; 2007 Feb; 27(1):86-92. PubMed ID: 17226745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central nervous system complications of HIV infection.
    Spudich SS; Ances BM
    Top Antivir Med; 2011; 19(2):48-57. PubMed ID: 21868822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings from the NIMH symposium on "NeuroAIDS in Africa: neurological and neuropsychiatric complications of HIV".
    Buch S; Chivero ET; Hoare J; Jumare J; Nakasujja N; Mudenda V; Paul R; Kanmogne GD; Sacktor N; Wood C; Royal W; Joseph J
    J Neurovirol; 2016 Oct; 22(5):699-702. PubMed ID: 27473196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 infection and cognitive impairment in the cART era: a review.
    Schouten J; Cinque P; Gisslen M; Reiss P; Portegies P
    AIDS; 2011 Mar; 25(5):561-75. PubMed ID: 21160410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CROI 2016: Neurologic Complications of HIV Infection.
    Spudich SS; Ances BM
    Top Antivir Med; 2016; 24(1):29-37. PubMed ID: 27398860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment.
    Spudich S; González-Scarano F
    Cold Spring Harb Perspect Med; 2012 Jun; 2(6):a007120. PubMed ID: 22675662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could differential virological characteristics account for ongoing viral replication and insidious damage of the brain during HIV 1 infection of the central nervous system?
    Vissers M; Stelma FF; Koopmans PP
    J Clin Virol; 2010 Dec; 49(4):231-8. PubMed ID: 20833583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1-associated CNS disease in infants and children.
    Belman AL
    Res Publ Assoc Res Nerv Ment Dis; 1994; 72():289-310. PubMed ID: 8115719
    [No Abstract]   [Full Text] [Related]  

  • 11. PET brain imaging in HIV-associated neurocognitive disorders (HAND) in the era of combination antiretroviral therapy.
    Vera JH; Ridha B; Gilleece Y; Amlani A; Thorburn P; Dizdarevic S
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):895-902. PubMed ID: 28058461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CROI 2017: Neurologic Complications of HIV Infection.
    Spudich SS; Ances BM
    Top Antivir Med; 2017; 25(2):69-76. PubMed ID: 28598791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variation and HIV-associated neurologic disease.
    Dahiya S; Irish BP; Nonnemacher MR; Wigdahl B
    Adv Virus Res; 2013; 87():183-240. PubMed ID: 23809924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.
    Strain MC; Letendre S; Pillai SK; Russell T; Ignacio CC; Günthard HF; Good B; Smith DM; Wolinsky SM; Furtado M; Marquie-Beck J; Durelle J; Grant I; Richman DD; Marcotte T; McCutchan JA; Ellis RJ; Wong JK
    J Virol; 2005 Feb; 79(3):1772-88. PubMed ID: 15650202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder.
    Letendre S
    Top Antivir Med; 2011 Nov; 19(4):137-42. PubMed ID: 22156215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-associated neurological disorders: a guide to pharmacotherapy.
    Tan IL; McArthur JC
    CNS Drugs; 2012 Feb; 26(2):123-34. PubMed ID: 22201342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV Neuropathogenesis in the Presence of a Disrupted Dopamine System.
    Nickoloff-Bybel EA; Calderon TM; Gaskill PJ; Berman JW
    J Neuroimmune Pharmacol; 2020 Dec; 15(4):729-742. PubMed ID: 32506353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening HIV-associated neurocognitive disorders (HAND) among HIV positive patients attending antiretroviral therapy in South Wollo, Ethiopia.
    Tsegaw M; Andargie G; Alem G; Tareke M
    J Psychiatr Res; 2017 Feb; 85():37-41. PubMed ID: 27821271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1-associated central nervous system dysfunction.
    Krebs FC; Ross H; McAllister J; Wigdahl B
    Adv Pharmacol; 2000; 49():315-85. PubMed ID: 11013768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurologic complications of HIV disease and their treatment.
    Letendre S; Ances B; Gibson S; Ellis RJ
    Top HIV Med; 2007; 15(2):32-9. PubMed ID: 17485785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.